New in the fight against pain!

20

May 2019

 

The Erchonia company is a world leader in the field of low energy laser applications. Over the past 17 years, Erchonia has conducted research with leading specialists around the world to develop the scientific discipline of cold lasers. Before the products were launched, their safety and efficacy were confirmed by clinical trials. Every day, thousands of Erchonia lasers are used to eliminate pain, accelerate healing, acne therapy and reduce body fat.

 

erchonia

 

FREQUENCY OF CHRONIC PAIN

It is estimated that over 56 million people a year in the United States suffer from chronic pain of various origins. Chronic pain is responsible for the largest number of absences at work in comparison with any other group of diseases, and its incidence is constantly increasing.

Most often, people who experience pain (back, joints, neck) reach for painkillers immediately in search of quick relief. The FDA recently issued a union warning
with the misuse and abuse of over-the-counter painkillers that cause severe complications such as stomach ulcers, hearing problems and liver failure.

What's more, doctors warn against the side effects of prescription painkillers.

 

SAFETY AND EFFECTIVENESS OF THERAPY CONFIRMED BY THE FDA

Erchonia low energy lasers offer clinically proven therapy that is safe and effective and has been approved by the FDA for:

  • Chronic neck pain
  • Postoperative pain
  • Shoulder pain
  • Pain associated with heel spur

 

HOW DOES A COLD LASER WORK?

 

erchonia

 

Low energy lasers (LLLT) or "cold lasers" are a non-invasive, painless, drug-free solution used in a wide range of therapies, including acute and chronic pain, body shaping, acne and reduction of cellulite visibility.

Receptors located in the cellular energy producing mitochondrion are able to absorb light at a specific wavelength. These receptors should be treated like other drug receptors. When we take medications, their components are absorbed by the body and localize the specific receptor based on the molecular structure and bind to this receptor. When the drug binds to the receptor, a secondary reaction occurs inside the cell. A similar mechanism can be observed when the body is exposed to light of a certain color. During therapy, light penetrates the skin and is then absorbed by the appropriate receptor. As a result of this stimulation, cell energy production increases, biochemical reactions, protein synthesis and growth factors occur, as well as cell proliferation and increased blood and oxygen flow.

Załączniki:

— Other news